XWELL, Inc. (NASDAQ:XWEL) Short Interest Up 464.4% in February

XWELL, Inc. (NASDAQ:XWEL) was the recipient of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 2,476,054 shares, a growth of 464.4% from the February 12th total of 438,683 shares. Based on an average daily volume of 36,407,898 shares, the short-interest ratio is presently 0.1 days. Approximately 49.9% of the shares of the stock are sold short. Approximately 49.9% of the shares of the stock are sold short. Based on an average daily volume of 36,407,898 shares, the short-interest ratio is presently 0.1 days.

XWELL Price Performance

XWELL stock opened at $1.40 on Wednesday. The stock has a market capitalization of $8.08 million, a P/E ratio of -0.42 and a beta of 0.87. XWELL has a 12-month low of $0.26 and a 12-month high of $2.20. The firm’s 50-day moving average is $0.60 and its two-hundred day moving average is $0.80.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of XWELL in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, XWELL currently has a consensus rating of “Sell”.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.